1. Home
  2. LCUT vs LITS Comparison

LCUT vs LITS Comparison

Compare LCUT & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifetime Brands Inc.

LCUT

Lifetime Brands Inc.

N/A

Current Price

$3.89

Market Cap

69.1M

ML Signal

N/A

LITS

Lite Strategy Inc.

N/A

Current Price

$1.38

Market Cap

55.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LCUT
LITS
Founded
1945
2000
Country
United States
United States
Employees
N/A
4
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.1M
55.9M
IPO Year
1991
N/A

Fundamental Metrics

Financial Performance
Metric
LCUT
LITS
Price
$3.89
$1.38
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
63.1K
501.7K
Earning Date
11-06-2025
11-17-2025
Dividend Yield
4.29%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$659,066,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.89
$1.46
52 Week High
$6.82
$9.00

Technical Indicators

Market Signals
Indicator
LCUT
LITS
Relative Strength Index (RSI) 46.76 N/A
Support Level $3.82 N/A
Resistance Level $4.11 N/A
Average True Range (ATR) 0.27 0.00
MACD -0.04 0.00
Stochastic Oscillator 23.33 0.00

Price Performance

Historical Comparison
LCUT
LITS

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Share on Social Networks: